Marshall JL - Search Results

1

Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses.

Marshall JL, Hoyer RJ, Toomey MA, Faraguna K, Chang P, Richmond E, Pedicano JE, Gehan E, Peck RA, Arlen P, Tsang KY, Schlom J. Marshall JL, et al. J Clin Oncol. 2000 Dec 1;18(23):3964-73. doi: 10.1200/JCO.2000.18.23.3964. J Clin Oncol. 2000. PMID: 11099326 Clinical Trial.

2

Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.

Wojtowicz-Praga S, Torri J, Johnson M, Steen V, Marshall J, Ness E, Dickson R, Sale M, Rasmussen HS, Chiodo TA, Hawkins MJ. Wojtowicz-Praga S, et al. J Clin Oncol. 1998 Jun;16(6):2150-6. doi: 10.1200/JCO.1998.16.6.2150. J Clin Oncol. 1998. PMID: 9626215 Clinical Trial.

3

Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.

Rizvi NA, Marshall JL, Ness E, Yoe J, Gill GM, Truglia JA, Loewen GR, Jaunakais D, Ulm EH, Hawkins MJ. Rizvi NA, et al. Among authors: marshall jl. Clin Cancer Res. 1998 Jun;4(6):1437-42. Clin Cancer Res. 1998. PMID: 9626460 Clinical Trial.

4

Phase I trial of orally administered pentosan polysulfate in patients with advanced cancer.

Marshall JL, Wellstein A, Rae J, DeLap RJ, Phipps K, Hanfelt J, Yunmbam MK, Sun JX, Duchin KL, Hawkins MJ. Marshall JL, et al. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2347-54. Clin Cancer Res. 1997. PMID: 9815633 Clinical Trial.

5

Biochemical modulation in the treatment of advanced cancer: a study of combined leucovorin, fluorouracil, and iododeoxyuridine.

Marshall JL, Richmond E, DeLap RJ. Marshall JL, et al. Clin Cancer Res. 1996 Sep;2(9):1475-80. Clin Cancer Res. 1996. PMID: 9816323

6

A pilot trial of GM-CSF and MDX-H210 in patients with erbB-2-positive advanced malignancies.

Posey JA, Raspet R, Verma U, Deo YM, Keller T, Marshall JL, Hodgson J, Mazumder A, Hawkins MJ. Posey JA, et al. Among authors: marshall jl. J Immunother. 1999 Jul;22(4):371-9. doi: 10.1097/00002371-199907000-00011. J Immunother. 1999. PMID: 10404439 Clinical Trial.

7

A Phase I study of LGD1069 in adults with advanced cancer.

Rizvi NA, Marshall JL, Dahut W, Ness E, Truglia JA, Loewen G, Gill GM, Ulm EH, Geiser R, Jaunakais D, Hawkins MJ. Rizvi NA, et al. Among authors: marshall jl. Clin Cancer Res. 1999 Jul;5(7):1658-64. Clin Cancer Res. 1999. PMID: 10430065 Clinical Trial.

8

Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen.

Marshall JL, Hawkins MJ, Tsang KY, Richmond E, Pedicano JE, Zhu MZ, Schlom J. Marshall JL, et al. J Clin Oncol. 1999 Jan;17(1):332-7. doi: 10.1200/JCO.1999.17.1.332. J Clin Oncol. 1999. PMID: 10458251 Clinical Trial.

9

A Phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancer.

Bhargava P, Marshall JL, Rizvi N, Dahut W, Yoe J, Figuera M, Phipps K, Ong VS, Kato A, Hawkins MJ. Bhargava P, et al. Among authors: marshall jl. Clin Cancer Res. 1999 Aug;5(8):1989-95. Clin Cancer Res. 1999. PMID: 10473076 Clinical Trial.

10

A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors.

Chen HX, Marshall JL, Ness E, Martin RR, Dvorchik B, Rizvi N, Marquis J, McKinlay M, Dahut W, Hawkins MJ. Chen HX, et al. Among authors: marshall jl. Clin Cancer Res. 2000 Apr;6(4):1259-66. Clin Cancer Res. 2000. PMID: 10778949 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

428 results

Search Page